Consolidation Therapy for Newly Diagnosed Pediatric Patients with High-Risk Neuroblastoma Using Busulfan/Melphalan, Autologous Hematopoietic Cell Transplantation, Anti-GD2 Antibody, Granulocyte-Macrophage Colony–Stimulating Factor, Interleukin-2, and Haploidentical Natural Killer Cells
- Resource Type
- Article
- Authors
- Talleur, Aimee C.; Triplett, Brandon M.; Federico, Sara; Mamcarz, Ewelina; Janssen, William; Wu, Jianrong; Shook, David; Leung, Wing; Furman, Wayne L.
- Source
- In Biology of Blood and Marrow Transplantation November 2017 23(11):1910-1917
- Subject
- Language
- ISSN
- 1083-8791